Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CDA-II versus cyclosporin A in lower-risk myelodysplastic syndromes
ChiCTR-IIR-17012778Phase 2Not yet recruiting
- Sponsor
- Shanghai Jiao Tong University Affiliated Sixth People’s Hospital
- Start
- Oct 2017
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label trial of cladribine and cyclosporine in myelodysplastic syndrome (MDS) (2 arms), sponsored by Shanghai Jiao Tong University Affiliated Sixth People’s Hospital. Primary endpoint: blood routine examination. Planned start Oct 2017; status: not yet recruiting.
02
Drugs
cladribinecyclosporine
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on ChiCTR-IIR-17012778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17012778.